Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
23.34
+0.28 (1.21%)
At close: Sep 22, 2026, 4:00 PM EDT
23.36
+0.02 (0.09%)
After-hours: Sep 22, 2026, 4:54 PM EDT
Odyssey Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The conference highlighted an innovation-driven pipeline targeting upstream immune pathways for durable remissions in inflammatory and autoimmune diseases. OD-001 showed promising phase IIa results in IBD, with rapid efficacy even in refractory patients. Multiple clinical readouts are expected by 2027, with a focus on rapid development and commercialization.